CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ginwa Enterprise Group Inc. Company Snapshot
Ginwa Enterprise Group Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ginwa Enterprise Group Inc. with three other companies in this sector in CHINA : Tibet Weixinkang Medicine Co Ltd (2019 sales of 740.96 million Chinese Renmimbi [US$108.54 million] of which 100% was Manufacture of Medicines), Chengdu Huasun Technology Group Co Ltd (745.34 million Chinese Renmimbi [US$109.18 million] of which 87% was Medicine Manufacturing), and Zhejiang Garden Bio-Chemical High-Tech Co Ltd (718.38 million Chinese Renmimbi [US$105.23 million] of which 99% was Food).

Sales Analysis. During the year ended December of 2019, sales at Ginwa Enterprise Group Inc. were 753.73 million Chinese Renmimbi (US$110.41 million). This is a very small increase of 1.3% versus 2018, when the company's sales were 744.13 million Chinese Renmimbi. Despite this increase, sales are still slightly below the level achieved in 2017, when Ginwa Enterprise Group Inc. reported sales of 756.60 million Chinese Renmimbi. The sales level in 2019 was fairly close to the level five years ago: in 2014, Ginwa Enterprise Group Inc. had sales of 712.79 million Chinese Renmimbi. Sales of Pharmaceutical Industry saw an increase that was more than double the company's growth rate: sales were up 8.4% in 2019, from 585.30 million Chinese Renmimbi to 634.71 million Chinese Renmimbi. Not all segments of Ginwa Enterprise Group Inc. experienced an increase in sales in 2019: sales of Pharmaceutical Commerce fell 27.9% to 86.96 million Chinese Renmimbi. Ginwa Enterprise Group Inc. also experienced decreases in sales in Hotel (down 13.5% to 36.68 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ginwa Enterprise Group Inc.
  Stock Performance Chart for Ginwa Enterprise Group Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 6.47
(Figures in Chinese Renmimbi)
1 Week 0.8%   13 Weeks 19.2%  
4 Weeks 30.2%   52 Weeks 4.0%  
 
Ginwa Enterprise Group Inc. Key Data:
  Ticker: 600080 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 753,726,003
(Year Ending Jan 2020).
Employees: 770
  Currency: Chinese Renmimbi Market Cap: 2,415,058,744
  Fiscal Yr Ends: December Shares Outstanding: 373,270,285
  Share Type: A Gu Closely Held Shares: 166,664,001
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.